DV
Dividend Vision

REGN — Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals Inc. (REGN)

REGN pays a 0.46% distribution rate, quarterly. Its Distribution Safety Score™ is 50 (Caution). Distributions grew 10.9% over the past year. Its deepest 1-year drawdown was 26.0%.

Regeneron Pharmaceuticals discovers, develops, manufactures, and commercializes medicines for eye diseases, allergies, inflammation, cardiovascular and metabolic conditions, neurological disorders, infectious diseases, and cancer. The company has a low current distribution rate and pays dividends quarterly. Regeneron appeals to growth-oriented investors seeking exposure to the pharmaceutical and biotechnology sector, though it is not primarily positioned as an income stock.

REGN key facts

Distribution Safety Score™
50 · Caution
Asset type
Stock
Asset class
Equity
Inception date
04/02/1991
Distribution rate
0.46%
Distribution frequency
Quarterly
Trailing yield
0.45%
Last close
$803.48
Market cap
$82,722,275,328
Average volume
425600.0
Last dividend
$0.9400
Ex-dividend date
08/18/2026
Payment date
08/31/2026
Beta
0.188
Payout ratio
0.0817
P/E ratio
19.898
Forward P/E
17.6367
EPS
$40.38